The Study
Molecular Mechanisms of Aspartame-Induced Kidney Renal Papillary Cell Carcinoma Revealed by Network Toxicology and Molecular Docking Techniques
This study is like using a computer to guess which LEGO pieces might be connected to a broken toy, based on pictures of other broken toys. It doesn't prove the toy broke because of those pieces — it just says, 'Maybe these pieces could be involved.' We don't even know if the toy was ever near those pieces.
Analysis score
Maximum 0 for a computational/algorithm study.
Where the score came from
Scientists used computers to study how a sweetener called aspartame might interact with genes in a rare kidney cancer. They found 8 genes that help predict who might live longer or shorter, and think aspartame might stick to these genes like a key in a lock.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 50 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1While the model is accurate, it doesn't prove aspartame causes cancer — it only shows a possible molecular link in patients who already have the disease.
- 2The 8-gene model predicted 1-year survival with 88% accuracy (AUC = 0.880).
- 3Aspartame was predicted to bind tightly to all 8 genes (binding energy < -5.0 kcal/mol).
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
International Journal of Molecular Sciences
Year
2025
Authors
Chen Huang, Lulu Wei, W. Yuan, Yaohong Lu, Gedi Zhang, Ziyou Yan
Related Content
Claims (5)
The International Agency for Research on Cancer has categorized aspartame as a substance that may cause cancer in humans, based on limited scientific evidence.
Computer simulations show that aspartame binds strongly to eight proteins linked to a type of kidney cancer, with binding strength below −5.0 kcal/mol.
Computational models suggest that aspartame may interact with biological pathways related to kidney cancer, including changes in the extracellular matrix, immune function, and metabolism, through shared gene targets.
Analysis of gene activity in 278 kidney cancer patients shows that the expression levels of eight specific genes, especially EDNRA, are linked to how long patients survive, indicating these genes could be used to classify patients by risk level.
Analysis of gene activity in 278 kidney cancer tumors shows increased activity in biological pathways involved in breaking down the extracellular matrix, regulating the immune environment around the tumor, and activating PI3K-Akt, TNF, and IL-17 signaling pathways.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.